Monday , July 6 2020
Home / FT Alphaville / Will big tobacco save us from the coronavirus? 

Will big tobacco save us from the coronavirus? 

Before today, searching Google for “coronavirus” and “bats” mostly delivered epidemiological research papers and some pretty grim looking soup. Now, however, there’s also this: Mindful that it’s April 1 we emailed BAT’s flacks (that’s £65bn British American Tobacco), who assured that it’s “100 per cent legitimate”. So fair enough, here’s the press release:BAT’s US bio-tech subsidiary, Kentucky BioProcessing (KBP), is developing a potential vaccine for COVID-19 and is now in pre-clinical testing. If testing goes well, BAT is hopeful that, with the right partners and support from government agencies, between 1 and 3 million doses of the vaccine could be manufactured per week, beginning in June.OK, let’s pause there. No vaccines for coronaviruses have been developed in the 70 or so years

FT Alphaville considers the following as important:

This could be interesting, too:

Bradford DeLong writes Blanchard: Reopening the Economy—Noted

Bradford DeLong writes Scalzi: Back Into Quarantine—Noted

John H. Cochrane writes Magical monetary theory full review

[email protected] (Cyril Morong) writes Some San Antonio hospitals willing to pay more for front line workers amid coronavirus pandemic

Before today, searching Google for “coronavirus” and “bats” mostly delivered epidemiological...

FT Alphaville
FT Alphaville is a free daily news and commentary service giving finance professionals the information they need, when they need it. In a world where market professionals are inundated with information there is a pressing need to edit and filter, and hopefully sow a few ideas along the way. That’s where the FT Alphaville team comes in.

Leave a Reply

Your email address will not be published. Required fields are marked *